$PFE Income Statement | Understand Stock

$PFE

$29.79 -$0.24 (0.8%) Close

$PFE Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Operations

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Revenues
Product
Royalty
Total revenues
Alliance revenues
Total revenues
Costs and expenses:
Cost of sales
Selling, informational and administrative expenses
Research and development expenses
Acquired in-process research and development expenses
Amortization of intangible assets
Restructuring charges and certain acquisition-related costs
(Gain) on completion of Consumer Healthcare JV transaction
Other (income)/deductions––net

Income from continuing operations before provision/(benefit) for taxes on income
Provision/(benefit) for taxes on income
Income from continuing operations
Discontinued operations––net of tax
Net income before allocation to noncontrolling interests
Less: Net income attributable to noncontrolling interests
Net income attributable to Pfizer Inc. common shareholders
Earnings per common share––basic:
Income from continuing operations attributable to Pfizer Inc. common shareholders (in dollars per share)
Discontinued operations––net of tax (in dollars per share)
Net income attributable to Pfizer Inc. common shareholders (in dollars per share)
Earnings per common share––diluted:
Income from continuing operations attributable to Pfizer Inc. common shareholders (in dollars per share)
Discontinued operations––net of tax (in dollars per share)
Net income attributable to Pfizer Inc. common shareholders (in dollars per share)
Weighted-average shares––basic (in shares)
Weighted-average shares––diluted (in shares)

Comments